tiprankstipranks
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ:SHPH
US Market

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Income Statement

17 Followers

Shuttle Pharmaceuticals Holdings, Inc. Income Statement

Last quarter (Q3 2023), Shuttle Pharmaceuticals Holdings, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Shuttle Pharmaceuticals Holdings, Inc.'s net income was $-1.79M. See Shuttle Pharmaceuticals Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20
Total Revenue
--$ 0.00$ 0.00
Cost of Revenue
----
Gross Profit
----
Operating Expense
$ 1.52M$ 1.69M$ 1.74M$ 509.52K
Operating Income
$ -1.47M$ -1.69M$ -1.74M$ -509.52K
Net Non Operating Interest Income Expense
$ -65.78K$ -896.88K$ -50.79K$ -39.63K
Other Income Expense
$ -6.81K$ -422.71K$ 641.65K$ -256.58K
Pretax Income
$ -4.20M$ -3.03M$ -1.15M$ -805.73K
Tax Provision
-$ -66.21K$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -2.50M$ -3.10M$ -1.26M$ -908.79K
Basic EPS
$ -0.33$ -0.29$ -0.09$ -0.07
Diluted EPS
$ -0.33$ -0.29$ -0.09$ -0.07
Basic Average Shares
$ 43.64M$ 10.35M$ 13.28M$ 13.28M
Diluted Average Shares
$ 43.64M$ 10.35M$ 13.28M$ 13.28M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 1.52M$ 1.69M$ 1.74M$ 509.52K
Net Income From Continuing And Discontinued Operation
$ -4.95M$ -3.03M$ -1.15M$ -805.73K
Normalized Income
$ -1.84M-$ -1.79M$ -549.15K
Interest Expense
--$ 50.79K$ 39.63K
EBIT
$ -3.19M$ -2.06M$ -1.10M$ -766.10K
EBITDA
$ -1.53M$ -1.11M$ -1.04M$ -711.15K
Currency in USD

Shuttle Pharmaceuticals Holdings, Inc. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis